When someone is diagnosed with early-stage oral cancer, the treatment decision doesn't stop at removing the tumour. Managing the neck — where cancer can silently spread — is often the harder question.

For decades, surgeons have had two options: remove neck lymph nodes prophylactically (elective neck dissection), or watch and wait. Both carry real trade-offs. Neck dissection can mean shoulder stiffness, nerve damage, visible scarring, and longer recovery. But waiting risks missing hidden spread until it's too late.

Here's the thing — studies show that nearly 70–80% of early oral cancer patients don't actually have cancer in their neck nodes. That means most are undergoing surgery they didn't need.

Sentinel node biopsy changes the equation.

Sentinel node biopsy is as per NCCN guidelines. The sentinel lymph node is the first node that receives drainage from the tumor. If it's clear, the remaining nodes almost certainly are too. By mapping this node using a radiotracer and removing only it for pathological analysis, surgeons can accurately stage the neck with far less intervention.

Only patients with a positive sentinel node go on to complete neck dissection—sparing the majority from unnecessary morbidity.

Evidence from high-volume European centers confirms that sentinel node-guided surgery offers regional control comparable to full neck dissection, with significantly better quality of life outcomes. It's already standard practice in Denmark and France.

Some caution is still warranted—particularly for floor-of-mouth tumors, where anatomical challenges can affect accuracy.

At a leading cancer hospital in Thane like KIMS Hospitals, precision oncology approaches like sentinel node biopsy are part of a broader commitment to individualized, evidence-based cancer care—treating patients smarter, not just more aggressively.